Showing results (1331-1340 of 1,373) with videos related to
Sort By:
Pageof 138
Blood|August 19, 2011
Bortezomib plus dexamethasone versus reduced-dose bortezomib, thalidomide plus dexamethasone as induction treatment before autologous stem cell transplantation in newly diagnosed multiple myelomaPhilippe Moreau, Herve Avet-Loiseau, Thierry Facon, et al.Haematologica|April 15, 2014
Age is a prognostic factor even among patients with multiple myeloma younger than 66 years treated with high-dose melphalan: the IFM experience on 2316 patientsMarie-Lorraine Chretien, Benjamin Hebraud, Valérie Cances-Lauwers, et al.Blood Advances|June 3, 2026
Daratumumab in Transplant-Ineligible or -Deferred Newly Diagnosed Multiple Myeloma: Minimal Residual Disease in CEPHEUSSonja Zweegman, Thierry Facon, Vania Hungria, et al.Asian Journal of Andrology|March 24, 2022
Torsion of the spermatic cord in adults: a multicenter experience in adults with surgical exploration for acute scrotal pain with suspected testicular torsionVan Thi Dang, Benjamin Pradere, Anne Mauger de Varennes, et al.The New England Journal of Medicine|May 30, 2019
Daratumumab plus Lenalidomide and Dexamethasone for Untreated MyelomaThierry Facon, Shaji Kumar, Torben Plesner, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 8, 2017
Prospective Evaluation of Magnetic Resonance Imaging and [18F]Fluorodeoxyglucose Positron Emission Tomography-Computed Tomography at Diagnosis and Before Maintenance Therapy in Symptomatic Patients With Multiple Myeloma Included in the IFM/DFCI 2009 Trial: Results of the IMAJEM StudyPhilippe Moreau, Michel Attal, Denis Caillot, et al.The Lancet. Haematology|March 28, 2020
Subcutaneous versus intravenous daratumumab in patients with relapsed or refractory multiple myeloma (COLUMBA): a multicentre, open-label, non-inferiority, randomised, phase 3 trialMaria-Victoria Mateos, Hareth Nahi, Wojciech Legiec, et al.Annals of Hematology|January 14, 2018
Salvage therapy post pomalidomide-based regimen in relapsed/refractory myelomaGuillemette Fouquet, Lionel Karlin, Margaret Macro, et al.Blood|October 31, 2015
Understanding the role of hyperdiploidy in myeloma prognosis: which trisomies really matter?Marie-Lorraine Chretien, Jill Corre, Valerie Lauwers-Cances, et al.Nature Communications|January 11, 2018
Guiding of relativistic electron beams in dense matter by laser-driven magnetostatic fieldsM Bailly-Grandvaux, J J Santos, C Bellei, et al.Pageof 138